Assessment of women's knowledge about HPV vaccination in the light of the HPV infection as a risk factor for cervical cancer
DOI:
https://doi.org/10.12775/JEHS.2020.10.09.078Keywords
HPV virus, HPV infection, cervical cancer, vaccines, vaccination,Abstract
Introduction Cervical cancer (CC) is one of the most prevalent malignancies of female reproductive tract. In Poland in 2017 CC accounted for 3.0% of all newly registered tumour cases among women, and was the eighth most common female malignancy. Persistent infection with carcinogenic human papillomavirus (HPV) is the leading risk facor. Currently, it is believed that infection with the human papillomavirus (HPV), especially its oncogenic types 16 and 18, is of fundamental importance in the development of cervical cancer.
Vaccination prevents from infection with certain types of viruses, and consequently the development of cancer induced by a given type of virus. Therefore, their efficacy can be measured only in the long term, in a large cohort of vaccinated adolescents reaching the age characterized by the peak incidence of these cancers.
Purpose The objective of the study was to evaluate knowledge about CC, as well as awareness of HPV and HPV vaccination among female respondents.
Material and method The research was conducted on the group of 1,260 survey respondents, who filled out the Internet questionnaire. The obtained results were analysed and checked on the basis of scientific literature.
Results The percentage of respondents who select human papillomavirus infection as a risk factor for the cervical cancer is 75.9%. The onset of intercourse at an early age was considered a risk factor by only 24.6%, while a large number of sexual partners by 45.4%. Women were also asked about knowledge of HPV vaccination. Only 73.8% of them heard about it and 26.2% declare unawarness of this type of vaccination.
Conclusions Health promotion campaigns and educational programs are necessary in order to reduce cervical cancer burden and should be directed particularly towards those who have demonstrated low cervical cancer knowledge and low awareness regarding HPV and its vaccine.
References
Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health. 2020;8(2):e191-e203.
Raporty | KRN http://onkologia.org.pl/raporty/ (Accessed September 17, 2020)
Rančić NK, Golubović MB, Ilić MV, et al. Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia. Medicina. 2020;56(8):406.
Jee B, Yadav R, Pankaj S, Shahi SK. Immunology of HPV-mediated cervical cancer: current understanding. International Reviews of Immunology. 2020;0(0):1-20.
Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1-17.
Nowicki A, Borowa I, Maruszak M. Zachowania zdrowotne kobiet w zakresie zapobiegania, wczesnego wykrywania stanów przedrakowych i raka szyjki macicy [Women health behaviours regarding prevention and early detection of precancerous lesions and cervical carcinoma]. Ginekol Pol. 2008;79(12):840-849.
Jach R, Sznurkowski JJ, Bidziński M, et al. Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of cervical cancer. Curr Gynecol Oncol. 2017;15(1):24-33.
Ulman-Włodarz I, Nowosielski K, Romanik M, Pozowski J, Jurek M. Swiadomość profilaktyki raka szyjki macicy wśród kobiet zgłaszajacych sie do poradni K [Awareness of cervical cancer prevention among patients of gynecological outpatient clinic]. Ginekol Pol. 2011;82(1):22-25.
Szczepionka przeciw HPV. Szczepienia.Info https://szczepienia.pzh.gov.pl/szczepionki/hpv/ (Accessed September 17, 2020)
Profilaktyka zakażeń wirusem brodawczaka ludzkiego (HPV) w ramach programów polityki zdrowotnej.
https://bipold.aotm.gov.pl/assets/files/ppz/2019/RPT/19.10.29_raport_zalec_techn_art_48aa_profilaktyka_hpv.pdf (Accessed September 17, 2020)
Li J, Kang J, Mao Y, et al. Investigating HPV- and HPV Vaccine-Related Knowledge, Perceptions, and Information Sources among Health Care Providers in Three Big Cities in China. Vaccines (Basel). 2020;8(3).
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 555
Number of citations: 0